InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,738.00
(
0.31%
)
Dow Jones
39,512.84
(
0.00%
)
Brent Oil
83.07
(
0.83%
)
Bitcoin
62,679.51
(
2.00%
)
Post# of 8169
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Cshom67

Send PM Follow Ignore
Followers 1
Posts 35
Boards Moderated 0
Alias Born 02/06/2017

Cshom67

Re: Snakers post# 5779

Friday, 02/24/2017 6:01:32 PM

Friday, February 24, 2017 6:01:32 PM

Post# of 8169
Yes they have received that - http://investor.cellectar.com/releasedetail.cfm?releaseid=886255

Will allow you to go with less patients per trial (vs. non-orphan indications) and potentially into a pivotal Ph2. They don't seem to have the data /outcomes for the latter though.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CLRB News
More CLRB News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!